Search

everythinglearnresearchcommunity

for

Search:↓

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Valproic acid is effective for various seizures, but may cause temporary side effects like drowsiness and stomach issues.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

Diphenylcyclopropenone (DPCP) is effective in treating alopecia areata, with most patients showing significant hair regrowth.

Low-dose flutamide-metformin therapy effectively improved PCOS symptoms in adolescent girls.

Xiaoaiping reduces chemotherapy side effects and improves quality of life for breast cancer patients.

Stingless bee propolis may help regenerate hair follicles and improve pigment function in chemotherapy-induced hair loss.

Personalized hair care strategies are needed for Black cancer patients to prevent hair loss during chemotherapy.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

Hippocampus sparing whole brain radiation therapy prevents hair loss and preserves cognitive function.

A cat's hair loss was linked to a severe pancreatic cancer.

Nanoformulated plant compounds show promise for treating PCOS but need more testing and validation.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Lifestyle changes are more effective than metformin in reducing type 2 diabetes risk in women with PCOS.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

Valproate can cause rare hair curling in some patients.

Pexidartinib often causes liver issues and fatigue, especially in women.

DPCP can help regrow hair in some people with severe alopecia.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Improved collaboration and education between dermatologists and oncologists can enhance care for chemotherapy-related hair loss.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

Combining soursop leaf extract with doxorubicin may improve breast cancer treatment and reduce side effects.

A new metformin-based treatment may effectively promote hair growth with fewer side effects.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

The new nanocarriers improve how well water-insoluble drugs dissolve and allow for controlled drug release.

Cooler scalp temperatures during chemotherapy may prevent hair loss.

Targeted cancer therapies can cause new side effects, requiring careful monitoring and management to ensure patient safety.

Mitotane changes steroid breakdown, affecting cortisol availability.